Travere Therapeutics logo
Travere Therapeutics TVTX
$ 18.67 -0.43%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Travere Therapeutics Income Statement 2011-2024 | TVTX

Annual Income Statement Travere Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

613 M 1.38 B 1.65 B 1.2 B - - - - - - - - -

Shares

74.3 M 63.8 M 59.8 M 47.5 M - - - - - - - - -

Historical Prices

8.25 21.7 27.5 25.2 15.5 21.6 23.9 19.6 15 12.8 10.6 4.5 -

Net Income

-90.2 M -65.8 M -180 M -169 M -146 M -103 M -59.7 M -47.9 M 117 M -111 M -33.8 M -14.8 K -23 K

Revenue

45.1 M 29.3 M 132 M 198 M 175 M 164 M 155 M 134 M 99.9 M 28.2 M - - -

Cost of Revenue

11.4 M 4.42 M 3.82 M 6.13 M 5.23 M 5.53 M 3.6 M 4.55 M - - 4.27 M 18.1 M -

Gross Profit

- - - - 170 M 159 M 151 M 129 M 97.7 M 27.6 M - - -

Operating Income

-94.2 M -86.7 M -199 M -176 M -137 M -80 M -53.8 M -58.2 M -50.7 M -79.8 M -24.8 M -30.3 M -

Interest Expense

11.3 M 11 M 19.7 M 19.1 M 18.8 M 9.81 M 4.42 M 4.73 M 7.7 M 7.4 M - 84.1 K -

EBITDA

-55.7 M -66 M -187 M -152 M -94.5 M -61.6 M -32.4 M -42.1 M -32.6 M -74.4 M -14 M -12.8 K -12.7 K

Operating Expenses

- - - - 285 M 239 M 202 M 187 M 144 M 107 M - - -

General and Administrative Expenses

266 M 198 M 126 M 136 M 129 M 104 M 104 M 98 M 79.5 M 59.6 M 16.9 M 12.8 K 12.7 K

All numbers in USD currency

Quarterly Income Statement Travere Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

77.8 M 77.5 M 77.1 M 75.4 M 76.3 M 76 M 68.2 M 64.3 M 64 M 63.6 M 63.1 M 62.5 M 60.8 M 60.6 M 56.3 M 52.2 M 50.9 M 44.8 M 43.1 M 43.1 M 42.9 M 42 M 41.4 M 41.4 M 40.7 M 40.1 M 39.7 M 39.4 M 38.7 M 39 M 38 M 37.9 M 37 M 36.7 M 36.5 M 36.5 M 35.7 M 35 M 27.2 M 26 M 26.7 M 25.6 M 23.3 M 18.4 M 15.4 M 12.3 M 10.7 M 107 K 3.51 M 3.06 M 2.5 M 107 K 107 K 107 K -

Net Income

-54.8 M -70.4 M -136 M - 151 M -85.6 M -86.3 M - -69.7 M -67 M -76 M - -35.6 M -39 M -53.9 M -122 M -22.5 M -26.1 M 808 K -30.3 M -36.5 M -38.7 M -41 M -7.46 M -54.5 M -22.3 M -18.4 M -17.6 M -17.8 M -13.2 M -11.1 M -8.6 M -37.1 M -13.4 M 11.2 M -2.47 M 106 M -25.5 M 39.7 M -29 M -18 M 11.8 M -75.7 M -12.8 M -12 M -4.92 M -4.87 M -3.66 K -30.3 M -30.3 M -30.3 M -3.52 K -10.6 K -7.05 K -

Revenue

62.9 M 54.1 M 41.4 M - 37.1 M 32.2 M 30.9 M - 28.1 M 54.2 M 48.5 M - 68.2 M 54.6 M 47.4 M 51 M 51.1 M 48.4 M 47.8 M 46.7 M 44.4 M 44.7 M 39.6 M 43.8 M 40.7 M 41.3 M 38.4 M 42.2 M 40.3 M 38.8 M 33.6 M - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

1.63 M 2.06 M 1.5 M - 1.29 M 1.45 M 4.14 M - 1.11 M 2.05 M 2.14 M - 1.59 M 1.65 M 1.64 M - 1.19 M 1.49 M 1.37 M - 1.51 M 979 K 1.02 M - 1.13 M 1.18 M 1.61 M - 925 K - - - - - - - - - - - - 3.85 M 2.08 M - - 358 K 930 K - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-56.1 M -67.7 M -139 M - -92.6 M -104 M -97.4 M - -82.6 M -65.5 M -66.1 M - -31.7 M -35.3 M -47.5 M -119 M -19.4 M -23.1 M -15.1 M -28.2 M -34.4 M -36.5 M -38.2 M -4.98 M -35.6 M -21.6 M -17.9 M -15.2 M -10.6 M -13.6 M -14.4 M -18.2 M -20.4 M -11.4 M -8.24 M -15.2 M -20.5 M -6.94 M -8.1 M -18.7 M -21.9 M -17.2 M -22.1 M -11.9 M -6.03 M -4.98 M -1.89 M - -8.46 M -4.74 M -3.56 M - - - -

Interest Expense

520 K -3.5 M 2.8 M - 335 K -201 K 2.9 M - 2.8 M 3 M 2.5 M - 654 K 216 K -1.09 M - 553 K 426 K -190 K - -496 K 125 K -302 K - -90 K -403 K 121 K - 557 K 382 K 126 K - 151 K -206 K 210 K 2.21 M -314 K 522 K 311 K -10.3 M 2.6 M -2.18 M - -874 K - -5 -41.6 K 500 26.8 K -26.5 K -17.3 K 500 1.5 K 1 K -

EBITDA

-45.3 M -57.8 M -129 M - -81.7 M -93.6 M -90.7 M - -77.5 M -57.9 M -59 M - -11.1 M -29.2 M -41.5 M -119 M -1.49 M -11.6 M -9.41 M -28.2 M -19.3 M -26.8 M -33.3 M -4.98 M -21.8 M -12.6 M -13.6 M -15.2 M 2.73 M -4.88 M -10.1 M -18.2 M -8.42 M -3.52 M -4.35 M -15.2 M -11.1 M -1.41 M -6.32 M -18.7 M -18.3 M -15.5 M -21.9 M -11.9 M -5.87 M -4.88 M -1.83 M - -8.39 M -4.7 M -3.56 M - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - 62.8 M - 78.8 M 81.2 M 77.8 M 48.8 M 76.3 M 62.9 M 56.3 M 57.4 M 50.9 M 52.4 M 48 M 55.5 M 54.3 M 44.7 M 37.2 M 45.7 M 48.5 M 31 M 25.5 M 32.8 M 30.2 M 22.9 M 22.1 M 11.9 M 5.15 M 5.1 M 1.89 M - 8.46 M 4.74 M 3.56 M - - - -

General and Administrative Expenses

65.6 M 64.8 M 64.2 M - 67.8 M 68.2 M 66 M - 52.4 M 53 M 46.8 M - 36.1 M 35 M 36.8 M - 32 M 35 M 33.1 M - 29.8 M 39 M 32.7 M - 26.1 M 25.1 M 26.5 M - 24.9 M 28.8 M 23.1 M - 23.5 M 23.2 M 19.1 M - 22.3 M 19.7 M 14.9 M - 17.4 M 9.58 M 15.1 M - 2.97 M 4.49 M 1.73 M 3.16 K 3 K 3.01 K 80.2 K 3.02 K 9.07 K 6.05 K -

All numbers in USD currency